Pigment epithelium-derived factor decreases outflow facility

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 10, 2013, Pages 6655-6661

  Rogers, Morgan E ^a   Navarro, Iris D ^a   Perkumas, Kristin M ^a   Niere, Shannon M ^b   Allingham, R Rand ^a   Crosson, Craig E ^c   Stamer, W Daniel ^a  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Aqueous humor; Glaucoma; Growth factors; Outflow facility; PEDF; Schlemm's canal; Trabecular meshwork; VEGF

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENUCLEATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMAN; HUMAN CELL; INTRAOCULAR HYPERTENSION; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RETINA BLOOD FLOW; SCHLEMM CANAL;

AQUEOUS HUMOR; GLAUCOMA; GROWTH FACTORS; OUTFLOW FACILITY; PEDF; SCHLEMM'S CANAL; TRABECULAR MESHWORK; VEGF;

ANIMALS; AQUEOUS HUMOR; BLOOD-RETINAL BARRIER; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM; EYE PROTEINS; FEMALE; GLAUCOMA; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; NERVE GROWTH FACTORS; SERPINS; SWINE; TRABECULAR MESHWORK;

EID: 84885458728     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12766     Document Type: Article

References (34)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Org. 2004;82: 844-851.
2. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429-440.
3. Wan Z, Woodward DF, Stamer WD. Endogenous bioactive lipids and the regulation of conventional outflow facility. Exp Rev Ophthalmol. 2008;3:457-470.
4. Grant WM. Clinical tonography. Trans Am Acad Ophthalmol Otolaryngol. 1951;55:774-781.
5. Johnstone MA, Grant WG. Pressure-dependent changes in structures of the aqueous outflow system of human and monkey eyes. Am J Ophthalmol. 1973;75:365-383.
6. Ablonczy Z, Prakasam A, Fant J, Fauq A, Crosson C, Sambamurti K. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase. J Biol Chem. 2009;284:30177-30186.
7. Ablonczy Z, Dahrouj M, Tang PH, et al. Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci. 2011;52:8614-8620.
8. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56:549-580.
9. Becerra SP, Sagasti A, Spinella P, Notario V. Pigment epitheliumderived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J Biol Chem. 1995;270:25992-25999.
10. Notari L, Baladron V, Aroca-Aguilar JD, et al. Identification of a lipase-linked cell membrane receptor for pigment epitheliumderived factor. J Biol Chem. 2006;281:38022-38037.
11. Cai J, Jiang WG, Grant MB, Boulton M. Pigment epitheliumderived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem. 2006;281:3604-3613.
12. Zhang SX, Wang JJ, Gao G, Parke K, Ma JX. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol. 2006;37:1-12.
13. Becerra SP, Fariss RN, Wu YQ, Montuenga LM, Wong P, Pfeffer BA. Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution. Exp Eye Res. 2004;78:223-234.
14. Ortego J, Escribano J, Becerra SP, Coca-Prados M. Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium. Synthesis and secretion into the aqueous humor. Invest Ophthalmol Vis Sci. 1996;37: 2759-2767.
15. Perruccio EM, Rowlette LL, Comes N, et al. Dexamethasone increases pigment epithelium-derived factor in perfused human eyes. Curr Eye Res. 2008;33:507-515.
16. Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M. Decrease of pigment epithelium-derived factor in aqueous humor with increasing age. Am J Ophthalmol. 2004;137:935-936.
17. Ogata N, Imaizumi M, Miyashiro M, et al. Low levels of pigment epithelium-derived factor in highly myopic eyes with chorioretinal atrophy. Am J Ophthalmol. 2005;140:937-939.
18. Stamer WD, Roberts BC, Howell DN, Epstein DL. Isolation, culture, and characterization of endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci. 1998;39:1804-1812.
19. Lei Y, Overby DR, Read AT, Stamer WD, Ethier CR. A new method for selection of angular aqueous plexus cells from porcine eyes: a model for Schlemm's canal endothelium. Invest Ophthalmol Vis Sci. 2010;51:5744-5750.
20. Lei Y, Overby DR, Boussommier-Calleja A, Stamer WD, Ethier CR. Outflow physiology of the mouse eye: pressure dependence and washout. Invest Ophthalmol Vis Sci. 2011;52: 1865-1871.
21. Overby D, Gong H, Qiu G, Freddo TF, Johnson M. The mechanism of increasing outflow facility during washout in the bovine eye. Invest Ophthalmol Vis Sci. 2002;43:3455-3464.
22. Stamer WD, Read AT, Sumida GM, Ethier CR. Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes. Exp Eye Res. 2009;89: 980-988.
23. Boussommier-Calleja A, Bertrand J, Woodward DF, Ethier CR, Stamer WD, Overby DR. Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. Invest Ophthalmol Vis Sci. 2012;53:5838-5845.
24. Gottanka J, Chan D, Eichhorn M, Lutjen-Drecoll E, Ethier CR. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci. 2004;45:153-158.
25. Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci. 1995; 36:478-489.
26. Underwood JL, Murphy CG, Chen J, et al. Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am J Physiol. 1999;277(2, pt 1): C330-C342.
27. Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M. Decreased levels of pigment epithelium-derived factor in eyes with neuroretinal dystrophic diseases. Am J Ophthalmol. 2004;137:1129-1130.
28. Shin YJ, Nam WH, Park SE, Kim JH, Kim HK. Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients. Mol Vis. 2012;18:2265-2270.
29. Smith CP, Steinle JJ. Changes in growth factor expression in normal aging of the rat retina. Exp Eye Res. 2007;85:817-824.
30. Asrani S, Freedman S, Hasselblad V, et al. Does primary intraocular lens implantation prevent "aphakic" glaucoma in children? J AAPOS. 2000;4:33-39.
31. Chang S. LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol. 2006;141:1033-1043.
32. Koreen L, Yoshida N, Escariao P, et al. Incidence of, risk factors for, and combined mechanism of late-onset open-angle glaucoma after vitrectomy. Retina. 2012;32:160-167.
33. Ecker SM, Hines JC, Pfahler SM, Glaser BM. Aqueous cytokine and growth factor levels do not reliably reflect those levels found in the vitreous. Mol Vis. 2011;17:2856-2863.
34. Pollreisz A, Funk M, Breitwieser FP, et al. Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranes. Exp Eye Res. 2013;108:48-58.